Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.
about
Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels.Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology.Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.
P2860
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy of pegylated interfer ...... a matched case-control study.
@en
Efficacy of pegylated interfer ...... a matched case-control study.
@nl
type
label
Efficacy of pegylated interfer ...... a matched case-control study.
@en
Efficacy of pegylated interfer ...... a matched case-control study.
@nl
prefLabel
Efficacy of pegylated interfer ...... a matched case-control study.
@en
Efficacy of pegylated interfer ...... a matched case-control study.
@nl
P2093
P2860
P1476
Efficacy of pegylated interfer ...... a matched case-control study.
@en
P2093
Akinori Kasahara
Harumasa Yoshihara
Hideki Hagiwara
Kazuhiro Katayama
Kiyoshi Mochizuki
Masahide Oshita
Nao Kurashige
Naoki Hiramatsu
Norio Hayashi
P2860
P304
P356
10.1007/S00535-011-0455-1
P577
2011-08-20T00:00:00Z